Related references
Note: Only part of the references are listed.Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
Fauzia K. Musasia et al.
NATURE COMMUNICATIONS (2022)
The challenges of a circumsporozoite protein-based malaria vaccine
Deepyan Chatterjee et al.
EXPERT REVIEW OF VACCINES (2021)
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
Melissa C. Kapulu et al.
JCI INSIGHT (2021)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Controlled Human Malaria Infection: Applications, Advances, and Challenges
Danielle I. Stanisic et al.
INFECTION AND IMMUNITY (2018)
Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy
Chris Y. Chiu et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study
Kwadwo A. Koram et al.
PLOS ONE (2016)
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum
NH Tolia et al.
CELL (2005)
Association between protection, against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendernicity in myanmar: Complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein
S Soe et al.
INFECTION AND IMMUNITY (2004)